RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-75190JF549
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Virus
Applications
ELISA, Functional
Label
Janelia Fluor 549
Antibody Source
Monoclonal Human IgG1 kappa Clone # RSHZ19 (Felvizumab)
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.
Reactivity Notes
Respiratory syncytial virus (RSV)
Specificity
This antibody is specific for the an epitope located between amino acids 417-432 of conserved fusion (F) protein of RSV.
Clonality
Monoclonal
Host
Human
Isotype
IgG1 kappa
Applications
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: RSV Fusion Protein
Alternate Names
Human respiratory syncytial virus, RSV, RSV fusion protein, Rsvgp08
Additional RSV Fusion Protein Products
Product Specific Notices
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...